Insiders · Profile

VAN VOORHEES SETH

CHIEF FINANCIAL OFFICER at NRX Pharmaceuticals · Chief Financial Officer at PDS Biotechnology · CFO & VP-Buisness Develpoment at RESEARCH FRONTIERS. Filing since 10 Feb 2011. CIK 0001284934

Company
Date
Role
Action
Shares
Amount
Of holding
16 Dec 2022
CHIEF FINANCIAL OFFICER
Bought
30,000
$33.00K
184%
25 Nov 2022
CHIEF FINANCIAL OFFICER
Bought
16,337
$18.22K
×408
15 Jun 2021
Chief Financial Officer
Bought
17,647
$150.00K
opened
12 Sep 2017
CFO & VP-Buisness Develpoment
Bought
4,000
$4.60K
3.0%
19 Jun 2014
CFO & VP-Business Development
Bought
2,000
$10.90K
1.5%
10 Feb 2011
VicePresident-Business Dev/CFO
Bought
12,000
$103.80K
50.0%
10 Feb 2011
VicePresident-Business Dev/CFO
Bought
12,000
$103.80K
opened
7 decisions on file.